Conditions: Carcinoma, Squamous Cell of Head and Neck; Carcinoma, Non-Small-Cell Lung; Small Cell Lung Carcinoma
Interventions: Drug: Durvalumab; Drug: Tremelimumab; Drug: Cisplatin (dose level 4); Drug: Cisplatin (dose level 3); Drug: Carboplatin (dose level 1); Drug: Carboplatin (dose level 2); Drug: Etoposide (dose level 1); Drug: Etoposide (dose level 2); Drug: Paclitaxel; Drug: Pemetrexed; Radiation: External beam radiation (dose level 1); Radiation: External beam radiation (dose level 2); Radiation: External beam radiation (hyperfractionated); Drug: Cisplatin (dose level 1); Drug: Cisplatin (dose level 2); Radiation: External beam radiation (standard)
Sponsor: AstraZeneca
Not yet recruiting
from #ORL via a.lsfakia on Inoreader https://ift.tt/2JuoLj3
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου